STAT3 and prostate cancer: In conclusion, we have shown that bone marrow-derived MSCs drive the emergence of apoptosis resistant subpopulations of prostate cancer cells via the chronic exposure to MSC-derived IL-28, and that this is associated with increases in STAT3 activity that are necessary for the maintenance of bone metastatic PCa.